Defined as quantities of antimicrobials used in a specific setting (total, community, hospital) during a specific period of time (e.g. days, months and year).

Refers to infectious microbes that have acquired the ability to survive exposures to clinically relevant concentrations of antimicrobial drugs that would kill otherwise sensitive organisms of the same strain. The phrase is also used to describe any pathogen that is less susceptible than its counterparts to a specific antimicrobial compound (or combination thereof).

Enables the implementation of countries’ NAPs. It does this by developing and executing a strong implementation plan, linked to the country’s national developmental agenda, joined up across sectors.

Refers to any agent used to kill or inhibit the growth of microorganisms (bacteria, viruses, fungi or parasites). This term applies whether the agent is intended for human, veterinary or agricultural applications.

A microbiological test to determine whether bacteria are susceptible or resistant to an antibiotic.